Frontiers | Network analysis of adverse event patterns following ...
Feb 19, 2025 · Keywords: COVID-19, mRNA vaccines, pharmacovigilance, adverse drug events, post-marketing drug surveillance, adverse drug reaction reporting systems Citation: Ferreira-da-Silva R, …
COVID-19 Vaccine Safety Surveillance | FDA
Jan 10, 2025 · In the United States, these are received and entered into the Vaccine Adverse Event Reporting System (VAERS), a national vaccine safety surveillance system that is co-managed by …
Jun 25, 2025 · Many potential safety outcomes were rigorously assessed through complementary passive and active systems Myocarditis is causally associated with mRNA COVID-19 vaccines …
Real-life safety profile of mRNA vaccines for COVID-19 ... - ScienceDirect
May 2, 2023 · Abstract Introduction Since the first COVID-19 messenger RNA vaccines became available globally for emergency or conditional use, post-marketing surveillance activities have been …
Safety of JN.1-Updated mRNA COVID-19 Vaccines - JAMA Network
Jul 28, 2025 · The figure shows adjusted incidence rate ratios (IRRs) for 29 adverse events of special interest to COVID-19 vaccines; rates observed during the 28-day risk period after booster …